Literature DB >> 15288285

Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases.

Sophie Camatte1, Philippe Morice, Anne Thoury, Virgine Fourchotte, Patricia Pautier, Catherine Lhomme, Pierre Duvillard, Damienne Castaigne.   

Abstract

The aim of this study was to assess the patient's clinical outcome following complete or incomplete surgical staging in cases treated for an early stage low-malignant-potential ovarian tumour (LMPOT). One-hundred and one patients treated between 1965 and 1998 for a early stage I LMPOT were reviewed according to whether the initial surgical staging was complete (Group 1/defined by peritoneal cytology + peritoneal biopsies + infracolic omentectomy) or incomplete (Group 2/omission of at least one of the peritoneal staging procedures described above). Complete and incomplete surgical stagings were carried out in 48 (48%) and 53 (52%) patients, respectively. Four (8%) LMPOT recurrences were observed in Group 2, all following conservative management, but there were no recurrences in Group 1. No relapses with invasive carcinoma or peritoneal disease and no tumour-related deaths were observed. The absence of complete peritoneal staging in patients with an apparent "stage I" LMPOT increased the recurrence rate. However, this surgical restaging (in cases of incomplete initial surgery) does not modify the survival of patients with apparent "stage I" LMPOT misdiagnosed during the initial surgery. This procedure could probably be omitted: (1) if the peritoneum is clearly reported as "normal" during the initial surgery; (2) in the absence of a micropapillary pattern; and (3) if the patient agrees to be carefully followed-up.

Entities:  

Mesh:

Year:  2004        PMID: 15288285     DOI: 10.1016/j.ejca.2004.04.017

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.

Authors:  Catherine Uzan; Aminata Kane; Annie Rey; Sebastien Gouy; Sophie Camatte; Patricia Pautier; Catherine Lhommé; Christine Haie-Meder; Pierre Duvillard; Philippe Morice
Journal:  Oncologist       Date:  2011-01-27

2.  S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Authors:  U Wagner; P Harter; F Hilpert; S Mahner; A Reuß; A du Bois; E Petru; W Meier; P Ortner; K König; K Lindel; D Grab; P Piso; O Ortmann; I Runnebaum; J Pfisterer; D Lüftner; N Frickhofen; F Grünwald; B O Maier; J Diebold; S Hauptmann; F Kommoss; G Emons; B Radeleff; M Gebhardt; N Arnold; G Calaminus; I Weisse; J Weis; J Sehouli; D Fink; A Burges; A Hasenburg; C Eggert
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

3.  Management of Borderline Ovarian Tumors-Still a Gray Zone.

Authors:  Nidhi Nayyar; Prerna Lakhwani; Ashish Goel; Pankaj Kr Pande; Kapil Kumar
Journal:  Indian J Surg Oncol       Date:  2017-08-25

4.  Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.

Authors:  Shu Hui Zhao; Jin Wei Qiang; Guo Fu Zhang; Feng Hua Ma; Song Qi Cai; Hai Ming Li; Li Wang
Journal:  Eur Radiol       Date:  2014-05-29       Impact factor: 5.315

5.  Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary.

Authors:  Jin Hwi Kim; Tae Jung Kim; Yong Gyu Park; Sung Ha Lee; Chung Won Lee; Min Jong Song; Keun Ho Lee; Soo Young Hur; Seog Nyeon Bae; Jong Sup Park
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

Review 6.  Borderline tumours of the ovary, current controversies regarding their diagnosis and treatment.

Authors:  María Guadalupe Patrono; Lucas Minig; Ivan Diaz-Padilla; Nuria Romero; Juan Francisco Rodriguez Moreno; Jesus Garcia-Donas
Journal:  Ecancermedicalscience       Date:  2013-12-17

Review 7.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

8.  Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.

Authors:  Yung-Taek Ouh; Dongwoo Kang; Hoseob Kim; Jae Kwan Lee; Jin Hwa Hong
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

9.  Histologic distribution of borderline ovarian tumors worldwide: a systematic review.

Authors:  Taejong Song; Yoo-Young Lee; Chel Hun Choi; Tae-Joong Kim; Jeong-Won Lee; Duk-Soo Bae; Byoung-Gie Kim
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

10.  External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours.

Authors:  S Bendifallah; C Uzan; R Fauvet; P Morice; E Darai
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.